Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.72 - $1.13 $4,280 - $6,717
-5,945 Reduced 10.82%
49,020 $45,000
Q3 2023

Nov 09, 2023

SELL
$0.91 - $2.29 $5,397 - $13,581
-5,931 Reduced 9.74%
54,965 $53,000
Q1 2023

May 12, 2023

BUY
$2.16 - $3.47 $259 - $416
120 Added 0.2%
60,896 $171,000
Q4 2022

Feb 09, 2023

SELL
$1.73 - $2.95 $2,392 - $4,079
-1,383 Reduced 2.22%
60,776 $136,000
Q3 2022

Nov 10, 2022

BUY
$2.39 - $3.96 $82,452 - $136,616
34,499 Added 124.73%
62,159 $149,000
Q2 2022

Aug 12, 2022

BUY
$1.75 - $10.44 $48,405 - $288,770
27,660 New
27,660 $80,000

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0

About Burning Rock Biotech Ltd


  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $716M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.